Malvern, PA, United States of America

John Lubinski

USPTO Granted Patents = 3 


 

Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2011-2019

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: John Lubinski: Innovator in Herpes Simplex Virus Vaccines

Introduction

John Lubinski is a notable inventor based in Malvern, PA (US). He has made significant contributions to the field of vaccine development, particularly focusing on Herpes Simplex Virus (HSV). With a total of 3 patents, Lubinski's work is paving the way for advancements in immunization against HSV.

Latest Patents

Lubinski's latest patents include innovative vaccines that combine two or more recombinant Herpes Simplex Virus proteins. These proteins are selected from gD, gC, and gE proteins. His inventions provide methods for vaccinating subjects against HSV, aiming to treat, suppress, inhibit, and reduce the incidence of HSV infections and their symptoms. The vaccines are designed to impede immune evasion by HSV, thereby enhancing the effectiveness of the immunization process.

Career Highlights

John Lubinski is affiliated with the University of Pennsylvania, where he continues to engage in groundbreaking research. His work has garnered attention for its potential impact on public health, particularly in the realm of viral infections.

Collaborations

Lubinski collaborates with esteemed colleagues such as Harvey M Friedman and Sita Awasthi, contributing to a rich environment of innovation and research.

Conclusion

John Lubinski's contributions to the development of Herpes Simplex Virus vaccines highlight his role as a key innovator in the field. His work not only advances scientific understanding but also holds promise for improving health outcomes related to HSV infections.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…